Literature DB >> 21709205

Estrogen receptor: a never ending story?

Antonio C Wolff, Mitch Dowsett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21709205     DOI： 10.1200/JCO.2011.35.4589

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein.

Authors:  Chi Tze Tiong; Chen Chen; Shi Jun Zhang; Jun Li; Anatoly Soshilov; Michael S Denison; Lawrence Soon-U Lee; Vincent H Tam; Shih Peng Wong; H Eric Xu; Eu-Leong Yong
Journal:  Carcinogenesis       Date:  2012-02-16       Impact factor: 4.944

2.  Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification?

Authors:  Dominique Sighoko; Juxin Liu; Ningqi Hou; Paul Gustafson; Dezheng Huo
Journal:  Oncologist       Date:  2014-05-07

3.  A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors.

Authors:  Jyothi S Prabhu; Aruna Korlimarla; Krisha Desai; Annie Alexander; Rohini Raghavan; Ce Anupama; Nandini Dendukuri; Suraj Manjunath; Marjorrie Correa; N Raman; Anjali Kalamdani; Msn Prasad; K S Gopinath; B S Srinath; T S Sridhar
Journal:  J Cancer       Date:  2014-01-23       Impact factor: 4.207

4.  Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimens.

Authors:  Rishi R Rawat; Daniel Ruderman; Paul Macklin; David L Rimm; David B Agus
Journal:  NPJ Breast Cancer       Date:  2018-09-04

5.  Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study.

Authors:  Elena Lopez-Knowles; Simone Detre; Margaret Hills; Eugene F Schuster; Maggie C U Cheang; Holly Tovey; Lucy S Kilburn; Judith M Bliss; John Robertson; Elizabeth Mallon; Anthony Skene; Abigail Evans; Ian Smith; Mitch Dowsett
Journal:  Breast Cancer Res       Date:  2022-09-12       Impact factor: 8.408

Review 6.  Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome.

Authors:  Ferdinando Mannello; Daniela Ligi
Journal:  BMC Cancer       Date:  2013-07-12       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.